Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11091464
Pyridazinone compounds and uses thereof
granted -
US 11090272
Lurasidone solid dispersion and preparation method thereof
granted -
US 11090361
Activin receptor type IIa variants and methods of use thereof
granted -
US 11091467
Modulators of THR-β and methods of use thereof
granted -
US 11090349
Plant extract obtained from Morus plant leaves, compositions containing same, method of extraction and uses thereof
granted -
US 11090313
Methods for inhibiting muscle atrophy
granted -
US 11090344
Adenovirus and immunomodulator combination therapy
granted -
US 11090269
Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances
granted -
US 11090332
Antigen specific mRNA cellular cancer vaccines
granted -
US 11090285
Treatment of circadian rhythm disorders
granted -
US 11090396
Compounds and methods for the detection of TRPV-6 cancers and drug delivery
granted -
US 11091525
Method of refolding an interleukin-2 (IL-2) protein
granted -
US 11090308
Methods of treating liver disorders or lipid disorders with a THR-beta agonist
granted -
US 11091472
PI-kinase inhibitors with anti-infective activity
granted -
US 11090311
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11083720
Indazole inhibitors of fructokinase (KHK) and methods of use in treating KHK-mediated disorders or diseases
granted -
US 11083801
Factor VIII mutation repair and tolerance induction
granted -
US 11084798
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors
granted -
US 11083736
Compositions comprising triterpenoids
granted -
US 11084850
Recombinant prefusion RSV F proteins and uses thereof
granted -
US 11084842
Glucopyranosyl derivative and use thereof
granted -
US 11084865
VEGF antagonist formulations suitable for intravitreal administration
granted -
US 11083799
Materials and methods for treatment of hereditary haemochromatosis
granted -
US 11083758
Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.